Patents by Inventor Thomas Fallon

Thomas Fallon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240117054
    Abstract: Multi-specific binding proteins that bind NKG2D receptor, CD 16, and FLT3 are described, as well as pharmaceutical compositions and therapeutic methods useful for the treatment of autoimmune disease or cancer.
    Type: Application
    Filed: October 14, 2020
    Publication date: April 11, 2024
    Inventors: Hemanta Baruah, Gregory P. Chang, Ann F. Cheung, Asya Grinberg, Zong Sean Juo, Thomas J. McQuade, Daniel Fallon, William Haney, Steven O'Neil, Ronnie Wei
  • Publication number: 20240065641
    Abstract: A monitor mount is configured to detachably secure a first monitor and/or a second monitor individually or concurrently. The first monitor is further configured to be detachably secured to the second monitor independently from either monitor being secured to the monitor mount. The second monitor includes a mounting area in which the first monitor is mounted, and the first monitor and the second monitor are configured such that the first monitor is interchangeably insertable into the mounting area from a first lateral direction and a second lateral direction that is opposite to the first lateral direction. Accordingly, the second monitor includes a dual-entry feature that enables the first monitor to be inserted from either lateral side of the second monitor.
    Type: Application
    Filed: August 27, 2021
    Publication date: February 29, 2024
    Applicant: Drägerwerk AG & Co. KGaA
    Inventors: Clifford M. Risher-Kelly, John C. Magill, Zachary Kurt Hennings, Thomas Swyst, Christopher Aiston, Andrew T. Provencher, Peter A. Lund, Joseph Fallon, Ricardo Luis FERNANDEZ
  • Patent number: 7641900
    Abstract: The effect of the action of collagenase in treating lesions containing collagen or mixed fibrin clots (e.g., burns or ulcers) is improved by applying collagenase to the wound in combination with an organogel and a phosphatidylcholine, of which lecithin is a readily available source, particularly when the collagenase is first mixed and stored with that choline and an organic solvent and is subsequently mixed with a second individually stored formulation comprising a gel-forming agent and water, the two formulations individually having satisfactory shelf lives and the resultant mixture being applied to the lesion promptly after being formed.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: January 5, 2010
    Assignee: Research Foundation of State University of New York
    Inventors: Harry Soroff, Marcia Simon, Thomas Fallon, Peter Fallon, Gabriele Hatch
  • Publication number: 20080250106
    Abstract: An email and message management system invention that rejects all emails and messages unless the messages pass acceptance filter criteria. Without any filtering this invention will refuse to accept all incoming email and messages, whereas current systems accept all email messages without filtering aids. The invention uses several acceptance filtering methods including: a list of acceptable origin message addresses, a list of acceptable origin domain addresses, an algorithm criterion that allows messages based on wildcard type comparisons, a rules method that provides a means to use logic directives, and a method that allows the use of Pass Key Codes to automatically accept messages and to enhance message security. The invention includes an administrative function to set up and maintain the acceptance criteria, provide notification to users of rejected emails, message traffic monitoring for system quality control, and control of a network of the inventions.
    Type: Application
    Filed: April 3, 2007
    Publication date: October 9, 2008
    Inventors: George Leslie Rugg, Kenneth Thomas Fallon
  • Publication number: 20060222639
    Abstract: The effect of the action of collagenase in treating lesions containing collagen or mixed fibrin clots (e.g., burns or ulcers) is improved by applying collagenase to the wound in combination with an organogel and a phosphotidylcholine, of which lecithin is a readily available source, particularly when the collagenase is first mixed and stored with that choline and an organic solvent and is subsequently mixed with a second individually stored formulation comprising a gel-forming agent and water, the two formulations individually having satisfactory shelf lives and the resultant mixture being applied to the lesion promptly after being formed.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 5, 2006
    Inventors: Harry Soroff, Marcia Simon, Thomas Fallon, Peter Fallon, Gabriele Hatch